Hua Medicine
China - ShanghaiBiotechnology
Focus: Hua Medicine is a Shanghai-based public biotechnology company focused on small-molecule drug development across metabolic diseases, respiratory, neurology, infectious diseases, and oncology. The company operates at the clinical-stage biotech scale with a diversified but early-stage pipeline.
Profile data last refreshed 17h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Hua Medicine
AI assessmentNot HiringNo open roles listed right now. Follow Hua Medicine to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Tianqi Pingchan Granule
Levodopa-Induced DyskinesiaClinical Trials (1)
NCT04173845Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia
N/AHelp build intelligence for Hua Medicine
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.